Incidental Mutation 'R0579:Il21'
ID |
56346 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Il21
|
Ensembl Gene |
ENSMUSG00000027718 |
Gene Name |
interleukin 21 |
Synonyms |
|
MMRRC Submission |
038769-MU
|
Accession Numbers |
|
Essential gene? |
Non essential
(E-score: 0.000)
|
Stock # |
R0579 (G1)
|
Quality Score |
145 |
Status
|
Validated
|
Chromosome |
3 |
Chromosomal Location |
37276908-37286785 bp(-) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
T to G
at 37281923 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Lysine to Glutamine
at position 74
(K74Q)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000124668
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000029273]
[ENSMUST00000161015]
|
AlphaFold |
Q9ES17 |
Predicted Effect |
possibly damaging
Transcript: ENSMUST00000029273
AA Change: K74Q
PolyPhen 2
Score 0.648 (Sensitivity: 0.87; Specificity: 0.91)
|
SMART Domains |
Protein: ENSMUSP00000029273 Gene: ENSMUSG00000027718 AA Change: K74Q
Domain | Start | End | E-Value | Type |
Pfam:IL15
|
4 |
142 |
7.2e-11 |
PFAM |
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000147691
|
Predicted Effect |
possibly damaging
Transcript: ENSMUST00000161015
AA Change: K74Q
PolyPhen 2
Score 0.648 (Sensitivity: 0.87; Specificity: 0.91)
|
SMART Domains |
Protein: ENSMUSP00000124668 Gene: ENSMUSG00000027718 AA Change: K74Q
Domain | Start | End | E-Value | Type |
signal peptide
|
1 |
22 |
N/A |
INTRINSIC |
low complexity region
|
26 |
38 |
N/A |
INTRINSIC |
PDB:3TGX|P
|
39 |
140 |
8e-36 |
PDB |
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000196943
|
Meta Mutation Damage Score |
0.0740 |
Coding Region Coverage |
- 1x: 99.4%
- 3x: 98.9%
- 10x: 97.4%
- 20x: 94.7%
|
Validation Efficiency |
89% (34/38) |
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the common-gamma chain family of cytokines with immunoregulatory activity. The encoded protein plays a role in both the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells including macrophages, natural killer cells, B cells and cytotoxic T cells. Dysregulation of this gene plays a role in multiple immune-mediated diseases including lupus, psoriasis and chronic inflammatory diseases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011] PHENOTYPE: Mice homozygous for disruptions in this gene develop normally and have a normal life span. One allele exhibits enhanced IgE isotype switch and IgE production after antigen immunization. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 39 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
4921517D22Rik |
GCC |
GC |
13: 59,839,412 (GRCm39) |
|
probably null |
Het |
Abcf3 |
G |
A |
16: 20,369,398 (GRCm39) |
R260Q |
probably benign |
Het |
Abcg3 |
A |
G |
5: 105,121,969 (GRCm39) |
V136A |
probably damaging |
Het |
Acr |
C |
G |
15: 89,453,678 (GRCm39) |
H72Q |
probably damaging |
Het |
Ambra1 |
A |
G |
2: 91,654,810 (GRCm39) |
N783S |
possibly damaging |
Het |
Cd300ld2 |
A |
G |
11: 114,903,125 (GRCm39) |
F240S |
probably benign |
Het |
Cep83 |
A |
G |
10: 94,584,915 (GRCm39) |
D340G |
possibly damaging |
Het |
Crybg2 |
T |
A |
4: 133,800,049 (GRCm39) |
I403N |
probably damaging |
Het |
Dnah14 |
T |
A |
1: 181,572,312 (GRCm39) |
M2881K |
possibly damaging |
Het |
Erbb4 |
T |
C |
1: 68,081,621 (GRCm39) |
M1138V |
probably benign |
Het |
Evi5 |
A |
G |
5: 107,969,575 (GRCm39) |
V112A |
probably benign |
Het |
F2r |
A |
G |
13: 95,754,857 (GRCm39) |
V9A |
probably benign |
Het |
Flot1 |
C |
A |
17: 36,141,900 (GRCm39) |
S337R |
probably benign |
Het |
Glt28d2 |
G |
A |
3: 85,779,440 (GRCm39) |
T11I |
probably damaging |
Het |
Gm19345 |
A |
G |
7: 19,588,901 (GRCm39) |
|
probably benign |
Het |
Gm6605 |
C |
A |
7: 38,147,699 (GRCm39) |
|
noncoding transcript |
Het |
Hmgcs2 |
A |
T |
3: 98,198,264 (GRCm39) |
I56F |
probably damaging |
Het |
Ifna9 |
T |
A |
4: 88,510,508 (GRCm39) |
T39S |
possibly damaging |
Het |
Itpripl1 |
G |
T |
2: 126,983,011 (GRCm39) |
Y370* |
probably null |
Het |
Kif24 |
G |
A |
4: 41,393,706 (GRCm39) |
P1056S |
probably damaging |
Het |
L2hgdh |
A |
T |
12: 69,748,046 (GRCm39) |
|
probably benign |
Het |
Lipo2 |
A |
T |
19: 33,724,298 (GRCm39) |
L156Q |
probably damaging |
Het |
Nlrp4c |
T |
A |
7: 6,063,844 (GRCm39) |
M84K |
probably benign |
Het |
Npy4r |
G |
A |
14: 33,868,640 (GRCm39) |
T216I |
probably benign |
Het |
Or12d17 |
T |
C |
17: 37,777,238 (GRCm39) |
V47A |
probably benign |
Het |
Or2h2c |
G |
C |
17: 37,422,347 (GRCm39) |
L176V |
probably benign |
Het |
Or6c1 |
A |
T |
10: 129,518,106 (GRCm39) |
C167* |
probably null |
Het |
Pafah1b2 |
T |
C |
9: 45,880,011 (GRCm39) |
E222G |
probably benign |
Het |
Pop1 |
T |
A |
15: 34,510,115 (GRCm39) |
D406E |
possibly damaging |
Het |
Proser1 |
A |
G |
3: 53,374,572 (GRCm39) |
Y32C |
probably damaging |
Het |
Ptprj |
C |
A |
2: 90,266,913 (GRCm39) |
|
probably null |
Het |
Slc1a3 |
T |
A |
15: 8,717,793 (GRCm39) |
I100F |
probably damaging |
Het |
Slc25a22 |
T |
C |
7: 141,011,272 (GRCm39) |
D176G |
probably damaging |
Het |
Stard7 |
T |
C |
2: 127,126,473 (GRCm39) |
V99A |
probably damaging |
Het |
Stk33 |
C |
T |
7: 108,924,904 (GRCm39) |
V184I |
probably damaging |
Het |
Timmdc1 |
A |
G |
16: 38,342,745 (GRCm39) |
L51P |
probably benign |
Het |
Tppp |
T |
C |
13: 74,169,352 (GRCm39) |
S31P |
probably benign |
Het |
Upf2 |
A |
T |
2: 5,993,240 (GRCm39) |
R599W |
unknown |
Het |
Vav1 |
G |
T |
17: 57,586,271 (GRCm39) |
W25L |
probably benign |
Het |
|
Other mutations in Il21 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
R0433:Il21
|
UTSW |
3 |
37,286,684 (GRCm39) |
missense |
possibly damaging |
0.46 |
R1641:Il21
|
UTSW |
3 |
37,286,681 (GRCm39) |
missense |
probably benign |
0.00 |
R1741:Il21
|
UTSW |
3 |
37,281,811 (GRCm39) |
missense |
probably benign |
0.00 |
R1754:Il21
|
UTSW |
3 |
37,279,674 (GRCm39) |
missense |
possibly damaging |
0.93 |
R1933:Il21
|
UTSW |
3 |
37,286,635 (GRCm39) |
missense |
probably benign |
|
R4560:Il21
|
UTSW |
3 |
37,279,633 (GRCm39) |
nonsense |
probably null |
|
R4975:Il21
|
UTSW |
3 |
37,286,653 (GRCm39) |
missense |
probably damaging |
0.99 |
R4977:Il21
|
UTSW |
3 |
37,286,653 (GRCm39) |
missense |
probably damaging |
0.99 |
R4979:Il21
|
UTSW |
3 |
37,286,653 (GRCm39) |
missense |
probably damaging |
0.99 |
R5254:Il21
|
UTSW |
3 |
37,281,884 (GRCm39) |
missense |
possibly damaging |
0.94 |
R5267:Il21
|
UTSW |
3 |
37,281,946 (GRCm39) |
missense |
probably benign |
|
R5641:Il21
|
UTSW |
3 |
37,281,917 (GRCm39) |
nonsense |
probably null |
|
R7058:Il21
|
UTSW |
3 |
37,286,629 (GRCm39) |
missense |
probably damaging |
1.00 |
R7259:Il21
|
UTSW |
3 |
37,281,803 (GRCm39) |
critical splice donor site |
probably null |
|
R9039:Il21
|
UTSW |
3 |
37,286,602 (GRCm39) |
missense |
probably benign |
|
R9249:Il21
|
UTSW |
3 |
37,279,677 (GRCm39) |
critical splice acceptor site |
probably null |
|
R9603:Il21
|
UTSW |
3 |
37,281,949 (GRCm39) |
missense |
possibly damaging |
0.94 |
|
Predicted Primers |
PCR Primer
(F):5'- TGCTCCATGCTAGTGATAACTGCG -3'
(R):5'- GAGTGACTTCAGCATAGCACCAGG -3'
Sequencing Primer
(F):5'- CATGCTAGTGATAACTGCGAACAAG -3'
(R):5'- TTTTCTCCCAGACAGGGAAGC -3'
|
Posted On |
2013-07-11 |